# DOJ

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/doj-company
Canonical HTML page: https://gethealthbrief.com/entity/doj-company

## Timeline

- **2026-03-13**: DOJ Missouri Filing — DOJ quietly asks the Missouri court to pause proceedings pending FDA review.
- **2026-03-11**: Legislative Action — Sen. Josh Hawley introduces a Senate bill to outright ban the abortion pill.
- **2026-01-20**: Louisiana Precedent — DOJ unsuccessfully asks Louisiana to pause its separate anti-abortion lawsuit.
- **2025-11-15**: Amended Complaint — AG Catherine Hanaway adds claims that mail-order drugs are dangerous without in-person visits.
- **2025-10-01**: Lawsuit Filed — Missouri, Kansas, and Idaho file suit against the FDA over mifepristone regulations.

## Recent coverage (1 stories)

### DOJ Requests Pause in Missouri Mifepristone Lawsuit Citing Internal FDA Review
2026-03-13 00:34:35 · Sentiment: Negative · Impact: 8/10 · Sources: 2

The U.S. Department of Justice has requested a federal court in Missouri to pause or dismiss a lawsuit targeting the FDA's approval of mifepristone, citing an ongoing internal agency review. This move reflects a strategic effort by the administration to manage high-stakes litigation over medication abortion and telehealth access ahead of the 2026 midterms.
Full story: https://gethealthbrief.com/story/doj-missouri-mifepristone-lawsuit-pause

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.